Cytotoxic And Cytostatic Effect Of Arecoline On Oral Fibroblast-A Review

Authors

  • Dr. Pallavi P. Channe, Dr. Mahesh Chavan, Dr. Ekta Gupta, Dr. Chandana Suddala, Dr. Fatru Rahman, Dr. Dheeraj Kumar Sharma

DOI:

https://doi.org/10.47750/pnr.2022.13.S10.236

Abstract

Areca nut (AN) is consumed by more than 600 million of individuals, particularly in some regions of South Asia, East Africa, and tropical Pacific, being classified as carcinogenic to humans. The most popular way of exposure consists of chewing a mixture of AN with betel leaf, slaked lime, and other ingredients that may also contain tobacco named betel quid (BQ). Arecoline is the principal active compound of AN, and, therefore, has been systematically studied over the years in several in vitro and in vivo genotoxicity endpoints. However, much of this information is dispersed, justifying the interest of an updated and comprehensive review article on this topic. In this sense, it is thus pertinent to describe and integrate the genetic toxicology data available as well as to address key toxicokinetics aspects of arecoline.

Downloads

Published

2022-12-31 — Updated on 2022-12-31

Issue

Section

Articles

How to Cite

Cytotoxic And Cytostatic Effect Of Arecoline On Oral Fibroblast-A Review. (2022). Journal of Pharmaceutical Negative Results, 2051-2055. https://doi.org/10.47750/pnr.2022.13.S10.236